Voloridge Investment Management LLC Grows Position in Chemed Co. (NYSE:CHE)

Voloridge Investment Management LLC boosted its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 201.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,626 shares of the company's stock after acquiring an additional 7,767 shares during the quarter. Voloridge Investment Management LLC owned 0.08% of Chemed worth $6,159,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also bought and sold shares of the stock. Neuberger Berman Group LLC grew its position in shares of Chemed by 1.2% in the 4th quarter. Neuberger Berman Group LLC now owns 501,562 shares of the company's stock worth $265,726,000 after buying an additional 5,809 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Chemed by 1.5% in the fourth quarter. Geode Capital Management LLC now owns 340,409 shares of the company's stock valued at $180,654,000 after acquiring an additional 4,966 shares in the last quarter. FMR LLC increased its position in Chemed by 18.9% during the 4th quarter. FMR LLC now owns 283,790 shares of the company's stock valued at $150,352,000 after purchasing an additional 45,174 shares during the period. JPMorgan Chase & Co. raised its holdings in Chemed by 8.2% in the 4th quarter. JPMorgan Chase & Co. now owns 266,786 shares of the company's stock worth $141,343,000 after purchasing an additional 20,310 shares in the last quarter. Finally, Epoch Investment Partners Inc. lifted its position in shares of Chemed by 5.1% in the 4th quarter. Epoch Investment Partners Inc. now owns 252,237 shares of the company's stock worth $133,635,000 after purchasing an additional 12,167 shares during the period. 95.85% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. Wall Street Zen upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada upped their target price on Chemed from $667.00 to $674.00 and gave the stock an "outperform" rating in a report on Monday, April 28th.

Insiders Place Their Bets

In related news, EVP Spencer S. Lee sold 1,500 shares of the company's stock in a transaction dated Friday, May 16th. The shares were sold at an average price of $577.99, for a total value of $866,985.00. Following the transaction, the executive vice president now owns 14,627 shares in the company, valued at $8,454,259.73. The trade was a 9.30% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the completion of the transaction, the chief executive officer now directly owns 102,679 shares of the company's stock, valued at $60,957,441.93. This trade represents a 1.91% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 7,500 shares of company stock valued at $4,401,120. 3.29% of the stock is currently owned by corporate insiders.

Chemed Trading Down 1.4%

Chemed stock traded down $7.92 on Wednesday, hitting $573.27. 92,331 shares of the stock traded hands, compared to its average volume of 103,309. The business's fifty day simple moving average is $582.46 and its 200 day simple moving average is $565.69. The firm has a market cap of $8.39 billion, a P/E ratio of 28.97, a price-to-earnings-growth ratio of 2.15 and a beta of 0.59. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $623.61.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, topping the consensus estimate of $5.59 by $0.04. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The business had revenue of $646.94 million for the quarter, compared to analyst estimates of $641.78 million. During the same quarter in the previous year, the firm posted $5.20 earnings per share. Chemed's quarterly revenue was up 9.8% on a year-over-year basis. As a group, analysts predict that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Shareholders of record on Thursday, May 29th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. The ex-dividend date of this dividend is Thursday, May 29th. Chemed's payout ratio is 9.74%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.